BCR and B-cell chronic lymphocytic leukemia: CD5+CD19+ B1a cells have been found in healthy individuals, in patients who suffer from autoimmune disorders but also in patients with CLL; notably in both situations CD5 expression on CD19 B cells could reflect tolerance mechanisms inhibiting BCR signaling [13, 14].